Elsevier,

The Lancet Regional Health - Europe, Volume 45, October 2024

Pre-conception vaccination, particularly with mRNA vaccines, is associated with significant reductions in adverse pregnancy outcomes.
Analysis of the research used as a basis for clinical guideline development underscores the insufficient consideration of sex and gender in the primary evidence base informing the 2019 ESC guideline recommendations for chronic coronary syndromes. The underrepresentation of women in cardiovascular research and guideline development poses challenges for accurately discerning possible sex- and gender-specific effects and tailoring recommendations to diverse patient needs. Addressing these gaps requires explicitly integrating sex and gender considerations into study designs and guideline creation processes and promoting inclusivity to optimize clinical care provision and improve outcomes for all individuals affected by ischemic heart diseases.
The chief implication of this study for public policy is to support recommendations towards high-priority vaccination against COVID-19 in pregnant women to avoid high risks of adverse pregnancy outcomes from COVID-19 especially in the 3rd trimester.
The main public health implication of all the available evidence is that COVID-19 vaccination is to be recommended to all women of reproductive age, especially those intending to become pregnant within a year.
The number of women referred to a clinic with pregnancy-associated cancer will increase as NIPT providers will be able to better recognize malignant-suspicious NIPT from foetal aneuploidy screening. Reporting malignancy suspicious-NIPT results may be a step forward in detecting cancers and could enable an earlier diagnosis and start of cancer therapy, especially for haematological malignancies and advanced solid tumours.

Compelling evidence shows that social risks and mental health are intertwined.

Disparities in health and health care exist across multiple dimensions. Greater recognition and understanding of the social determinants of health has led to a considerable amount of research on the ways racism affects health outcomes, socioeconomic status, insurance status, the physical environment, and more.

Elsevier,

"Racial, Ethnic, and Socioeconomic Differences in Critical Care Near the End of Life 
Hauschildt, Katrina E. et al.
Critical Care Clinics, Volume 40, Issue 4, 753 - 766"

Patients from groups that are racially or ethnically minoritized or of low socioeconomic status receive more intensive care near the end of life than others, in part, due to their higher propensity to be admitted to high treatment-intensity hospitals.

This study examines the impact of science outreach programs on university researchers working with vulnerable populations.

Pages